- Coordinator
- Intelligent Implants Sweden AB, Sweden
- Runs
- 1 April 2022 to 30 November 2024
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €3.9m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190159768
What the project is doing
In the project's own words, from its summary on CORDIS.
Spinal surgery has a significant failure rate of 18% leading to devastating complications for patients. With the knowledge that bone remodels naturally using electric signals, we are transferring cutting edge neuromodulation technology into the orthopaedic field. We incorporate our proprietary, wirelessly powered bio-electrical stimulation system into standard orthopaedic implants. Our first product, SmartFuse, addresses the issues of non-union and bone overgrowth in spinal fusion surgery by harnessing the local delivery of electrical stimulation to accelerate bone growth and control the formation of new bone.
In addition to accelerating and controlling bone growth, SmartFuse can measure the quantity and quality of new bone, enabling real-time feedback on the progress of healing to the physician and other caregivers. Through EIC funding, we will complete a clinical pilot trial, and prepare a pivotal study demonstrating efficiency and safety to achieve the necessary market approvals.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Intelligent Implants Sweden AB | Mölndal | Sweden | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI